30.11.-1	Idera Pharma : Idera Pharmaceuticals to Participate at BIO InvestorForum 2007
30.11.-1	Idera Pharma : Idera Pharmaceuticals Announces the Appointment of Hans Mueller, Ph.D., to Its Board of Directors
30.11.-1	Idera Pharma : Idera Pharmaceuticals Presents Preclinical Data on IMO-2125 and Other TLR9 Agonists
30.11.-1	Idera Pharma : Idera Pharmaceuticals Initiates Phase 1 Trial of IMO-2125 in Hepatitis C
30.11.-1	Idera Pharma : Idera Pharmaceuticals to Participate in Upcoming Conferences

Unternehmensprofil

Beschäftigte

Sektor